Since EGFR (a member of the RTK family) is aberrantly overexpressed and activated in ovarian cancer [33,34], we first investigated whether p53R248Q overexpression affected EGFR downstream signaling in OVCAR3 cells (HGSOC cell line with p53R248Q). The gene discussed is EGFR; the disease is ovarian carcinoma.